Exploring breast and prostate cancer RNA-seq derived radiosensitivity with the Genomic Adjusted Radiation Dose (GARD) model

The use of a 10 gene transcriptional signature as part of the GARD model has been shown to be predictive of radiotherapy benefit for a range of cancers, with the potential to determine an optimal overall dose per patient. We used publicly available RNA-seq transcriptomics data from a luminal B breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolan, Ben, O’Sullivan, Brian, Golden, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396042/
https://www.ncbi.nlm.nih.gov/pubmed/36017133
http://dx.doi.org/10.1016/j.ctro.2022.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396042/
https://www.ncbi.nlm.nih.gov/pubmed/36017133
http://dx.doi.org/10.1016/j.ctro.2022.08.002

Ejemplares similares